Trudeau Institute Inc.

Saranac Lake, NY

UEI
N6K7XKLGRJ61
CAGE
3R402
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Non-Profit Organization
Entity structure
Corporate Entity (Tax Exempt)
SAM.gov registration date
Physical address
154 Algonquin Ave, Saranac Lake, NY 12983, USA
Founded
1884
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Consumer Staples
  2. Food, Beverage & Tobacco
  3. Food Products
  4. Agricultural Products
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
Research & development W911QY11C0013 Defense Contract Management Agency $989,549
Research & development for invluenza vaccine efficacy W911QY09C0014 ACC Aberdeen Proving Ground $2,599,128
Delivery Order N0001483C0407-E612B198507C1818N0001483C0407 Office of Naval Research (SECNAV) $64,000
Delivery Order N0001483C0407-E612B198405C1339N0001483C0407 Office of Naval Research (SECNAV) $59,000
Definitive Contract N0001483C0407-E612B198305D1625N0001483C0407 Office of Naval Research (SECNAV) $55,000

Grant awards

Award Agency Obligated Awarded
Probing the novel mechanism of action of tuberculocidal compounds R21AI194706 National Institute of Allergy and Infectious Diseases (NIH) $332,414
Optimization of antitubercular compounds against a novel mycobacterium tuberculosis target, aspc - tuberculosis (TB) is… R01AI195815 National Institute of Allergy and Infectious Diseases (NIH) $921,320
Development of a mouse model of tuberculosis that generates human-like pathology R21AI159731 National Institute of Allergy and Infectious Diseases (NIH) $841,500
A novel drug retargeting platform for drug-resistant bacterial infections R21AI144386 National Institute of Allergy and Infectious Diseases (NIH) $1,039,500
Zika virus countermeasures pre-clinical pregnancy models to assess protective efficacy against placental damage and… W81XWH1920019 Medical Command (Army) $1,286,365

Latest 5 listed here. See the rest on GovTribe.

Grant subawards

Prime recipient Prime award Amount Awarded
University Of Maryland, Baltimore Shark nanobodies identify pan-coronavirus spike sites of vulnerability for therapeutic intervention. R01AI192916 $201,849
International Aids Vaccine Initiative Inc. Trudeau-ITVD-Mouse Challenge Study 6 R61AI169132 $98,390
International Aids Vaccine Initiative Inc. Trudeau-ITVD-Guinea Pig Challenge Study 1 & 2 R61AI169132 $292,705
International Aids Vaccine Initiative Inc. Trudeau-ITVD-Mouse Challenge Study 7 R61AI169132 $86,510
San Diego State University Foundation Acting as a consultant for the project, Sub PI from Trudeau Institute in Saranac Lake, New York will perform the following tasks for this period of performance:… R01AI163202 $118,800

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

Vendor Location Primary NAICS
The Global Alliance For TB Drug Development Inc. UEI CA1RNRESAZU6 New York, NY 541714 Research and Development in Biotechnology (except Nanobiotechnology)
The Scripps Research Institute, Inc. UEI PHZJFZ32NKH4 San Diego, CA 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Applied Biomedical Science Institute UEI K6YFV76PCGB7 San Diego, CA —
Health Research At The Wadsworth Center UEI LQK1DD1EYZK9 Menands, NY 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Institut Pasteur UEI JRDEJNVPC8T3 Paris, Île-de-France 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Trudeau Institute Inc., a tax-exempt non-profit research organization based in Saranac Lake, New York, acts as a prime recipient of federal research grants focused on tuberculosis and infectious disease therapeutics, with ancillary subcontractor support on vaccine development and coronavirus research programs. The institute operates predominantly as a grant recipient (85% of recent awards) under the National Institutes of Health, particularly the National Institute of Allergy and Infectious Diseases (NIAID), with no federal contract prime awards in the source data.

Trudeau's research portfolio centers on tuberculosis drug development and preclinical animal model development for infectious disease therapeutics. Two recent NIAID Project Grants exemplify the scope: a $921,320 grant awarded January 28, 2026, through December 31, 2030, to optimize antitubercular compounds targeting alanine aminotransferase (ASPC), a novel Mycobacterium tuberculosis enzyme, advancing lead compound TI-374 toward clinical viability; and a $332,414 grant awarded February 9, 2026, through January 31, 2028, to characterize tuberculocidal compound TI-507, validating its mechanism against NAD kinase (PPNK) using laboratory and murine infection models. An earlier NIAID grant dated March 1, 2022, through February 29, 2024, supported development of a mouse model of tuberculosis generating human-like pathology, addressing predictive limitations in current preclinical testing. The institute's capability in animal model development and infectious disease research attracts secondary roles on vaccine development programs; Trudeau serves as a sub-recipient under International AIDS Vaccine Initiative prime grants conducting mouse and guinea pig challenge studies for mRNA vaccine candidates (awards dated January 2024 through May 2026), and as a consultant sub-recipient under Columbia University and University of Maryland Baltimore primes on coronavirus vaccine and therapeutic delivery research.

Customer concentration is extreme. NIAID and the broader National Institutes of Health account for 92% of awards by count (39 and 15 awards respectively under the NIH parent entity). The Department of the Navy Bureau of Medicine and Surgery holds a single award with $2.6 million potential value; the Department of the Army Materiel Command holds a $994 thousand award. Awards per year show recent acceleration: one award in 2022, six in 2024, and six in 2026 year-to-date. Only one award faces ultimate completion within the next twenty-four months, creating minimal recompete cliff exposure. Combined obligated dollars ($40.2 million) significantly exceed combined potential value ($3.6 million), reflecting long-duration grants with multi-year funding cycles characteristic of NIH research awards.

Quick answers

Is Trudeau Institute Inc. registered in SAM.gov?

Yes. Trudeau Institute Inc.'s SAM.gov registration is active through September 4, 2027.

What is Trudeau Institute Inc.'s most recent federal award?

Trudeau Institute Inc.'s most recent federal grant award is Probing the novel mechanism of action of tuberculocidal compounds (R21AI194706), from National Institute of Allergy and Infectious Diseases (NIH), on February 9, 2026.

On GovTribe

See Trudeau Institute Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login